Wuhan Hvsen Biotechnology Co.,Ltd. (SHE:300871)
China · Delayed Price · Currency is CNY 21.25
+0.39 (1.87%)
Aug 4, 2026, 3:04 PM CST
Wuhan Hvsen Biotechnology Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 398.32 | 310.2 | 326.14 | 293.61 | 424.04 | 1,068 |
Trading Asset Securities | 211.93 | 160.33 | 200.97 | 304.26 | 361.68 | 30.22 |
Cash & Short-Term Investments | 610.25 | 470.53 | 527.11 | 597.87 | 785.72 | 1,098 |
Cash Growth | 7.13% | -10.73% | -11.83% | -23.91% | -28.47% | 39.57% |
Accounts Receivable | 539.16 | 456.32 | 446.27 | 369.11 | 354.41 | 249.4 |
Other Receivables | 17.35 | 24.74 | 19.8 | 7.42 | 1.7 | 10.07 |
Receivables | 556.52 | 481.06 | 466.07 | 376.53 | 356.11 | 259.46 |
Inventory | 275.56 | 267.89 | 248.16 | 228.67 | 199.01 | 231.55 |
Other Current Assets | 56.6 | 87.45 | 71.24 | 62.91 | 10.64 | 9.42 |
Total Current Assets | 1,499 | 1,307 | 1,313 | 1,266 | 1,351 | 1,599 |
Property, Plant & Equipment | 1,537 | 1,551 | 1,543 | 1,566 | 1,498 | 1,007 |
Goodwill | 0.52 | 0.52 | - | - | - | - |
Other Intangible Assets | 109.54 | 110.57 | 114.44 | 104.17 | 106.87 | 110.06 |
Long-Term Deferred Tax Assets | 25.56 | 23.45 | 27.17 | 21.65 | 12.91 | 10.46 |
Long-Term Deferred Charges | 0.86 | 0.95 | 1.9 | 2.72 | 0.37 | - |
Other Long-Term Assets | 74.12 | 14.9 | 15.25 | 14.78 | 19.4 | 15.46 |
Total Assets | 3,248 | 3,009 | 3,015 | 2,975 | 2,989 | 2,742 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 442 | 391.2 | 507.3 | 472.47 | 489.7 | 311.33 |
Accrued Expenses | 20.52 | 34.47 | 22.88 | 26.72 | 33.67 | 27.59 |
Short-Term Debt | 185.88 | 173.85 | 316.78 | 240.32 | 220.08 | 100 |
Current Portion of Long-Term Debt | 16.01 | 30.03 | 16.32 | 0.27 | - | - |
Current Portion of Leases | - | - | - | - | - | 6.42 |
Current Income Taxes Payable | 24.22 | 11.02 | 0.04 | 3.17 | 6.25 | 2.56 |
Current Unearned Revenue | 23.57 | 19.51 | 13.47 | 10.27 | 15.62 | 13.87 |
Other Current Liabilities | 65.66 | 80.26 | 46.52 | 27.86 | 39.6 | 41.5 |
Total Current Liabilities | 777.87 | 740.33 | 923.32 | 781.08 | 804.93 | 503.27 |
Long-Term Debt | 140.16 | 24.72 | 555.45 | 601.66 | 570.36 | 574.56 |
Long-Term Unearned Revenue | 57.74 | 52.57 | 58.34 | 62.34 | 48.89 | 42.08 |
Long-Term Deferred Tax Liabilities | 2.71 | 2.8 | 11.37 | 20.26 | 21.82 | - |
Other Long-Term Liabilities | 1.75 | 1.75 | 1 | 0.85 | 1.69 | 2.9 |
Total Liabilities | 980.24 | 822.17 | 1,549 | 1,466 | 1,448 | 1,123 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 201.78 | 202.33 | 165.77 | 165.89 | 166.05 | 166.25 |
Additional Paid-In Capital | 1,439 | 1,451 | 880.63 | 874.01 | 877.08 | 881.6 |
Retained Earnings | 619.43 | 541.76 | 330.21 | 394.92 | 427.11 | 429.31 |
Treasury Stock | -1.3 | -18.09 | -17.57 | -52.42 | -55.73 | -9.52 |
Comprehensive Income & Other | -4.45 | -3.78 | 98.54 | 126.89 | 126.92 | 151.21 |
Total Common Equity | 2,255 | 2,174 | 1,458 | 1,509 | 1,541 | 1,619 |
Minority Interest | 13.39 | 12.78 | 7.63 | - | - | - |
Shareholders' Equity | 2,268 | 2,186 | 1,465 | 1,509 | 1,541 | 1,619 |
Total Liabilities & Equity | 3,248 | 3,009 | 3,015 | 2,975 | 2,989 | 2,742 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 342.05 | 228.6 | 888.56 | 842.24 | 790.45 | 680.98 |
Net Cash (Debt) | 268.2 | 241.93 | -361.45 | -244.38 | -4.72 | 417.47 |
Net Cash Growth | - | - | - | - | - | -41.03% |
Net Cash Per Share | 1.33 | 1.23 | -2.18 | -1.47 | -0.03 | 2.52 |
Filing Date Shares Outstanding | 201.78 | 201.78 | 165.01 | 163.5 | 163.67 | 166.25 |
Total Common Shares Outstanding | 201.78 | 201.58 | 165.01 | 163.5 | 163.67 | 166.25 |
Working Capital | 721.05 | 566.6 | 389.27 | 484.9 | 546.55 | 1,096 |
Book Value Per Share | 11.17 | 10.78 | 8.83 | 9.23 | 9.42 | 9.74 |
Tangible Book Value | 2,145 | 2,063 | 1,343 | 1,405 | 1,435 | 1,509 |
Tangible Book Value Per Share | 10.63 | 10.23 | 8.14 | 8.59 | 8.77 | 9.08 |
Buildings | - | 673.15 | 670.73 | 647.31 | 521.54 | 385.01 |
Machinery | - | 1,305 | 1,231 | 1,135 | 798.62 | 204.86 |
Construction In Progress | - | 58.93 | 18.15 | 53.13 | 332.51 | 473.25 |